Facebook
Twitter
LinkedIn

Newsletter

FAST Participant Secures $5M from Wellcome Trust
Facebook
Twitter
LinkedIn

Wellcome Trust awarded $5 million to Omniox, Inc., an inaugural participant in BayBio’s advisory program.

The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. The Trust spends around £600 million every year, both in the UK and internationally, supporting the brightest minds in biomedical research and the medical humanities.

Omniox, a BayBio member since 2009, participated in BayBio’s inaugural Fellows All-Star Team (FAST) Advisory Program last fall.  The team-based business advising program connects qualified startups with the strength and experience of the world’s leading life science cluster. The program draws on a high-level team of advisors to provide experience, contacts and counsel to qualified applicants, and is made possible through the generous support of Abbott Diabetes, Bayer Healthcare, and Pfizer.

The FAST Advisory Program provides selected entrepreneurs with the expert feedback needed to prove their business model and develop a compelling commercialization strategy. Experienced entrepreneurs, product and business experts (which may include clinical development, regulatory, reimbursement and business development specialists) will advise selected Fellows during an eight-week program, culminating in a Final Fellow Pitch Showcase to a broad audience that includes potential investors.

The Call for Applications for the Spring FAST cycle is open. For more information on the program and to apply for the spring cycle, visit www.baybio.org/fast.